Clinical Trials Browser

Neuroinflammatory Diseases × CNS × Clear all

Neuroinflammatory Diseases, Hypoxia, Brain Neoplasms

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

Clinical Trials

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent